Post Profile






Why Theranos Should Return Its Capital To Investors

Theranos, the formerly $9 billion company thatFORBESrevalued in July at$800 million, will shutter all its blood testing facilities. That's exactly what I wrote Theranos should do last July. And nowthe companyought to return to its investors whatever capital still remains on its balance sheet. Theranos's spokesperson Patrick Ryan declined to comment. On October [...]
read more

share

Related Posts


Discredited Blood Testing Company Theranos Shuts Down Facilities, Fires 40 Percent of Its Staff 

Pop Culture / Celebrity : Jezebel

Blood testing startup Theranos announced Wednesday that it’s shutting down its blood testing facilities and laying off more than 40 percent of its staff, the Wall Street Journal reports. The move comes after reports that Theranos’ p...

Theranos is facing a criminal investigation for reportedly misleading investors

Business & Finance : Business Pundit

Theranos, the troubled blood testing startup, is facing a criminal investigation into whether it misled investors. The startup which is valued at $9 billion, has come under fire after reports found irregularities with its tests. The...

Theranos is being sued for inaccurate blood tests and false marketing

Business & Finance : Business Pundit

$9 billion startup Theranos is being sued in Northern California. The company is accused of falsely marketing its proprietary finger-prick blood test. The lawsuit says Theranos promoted itself as being compliant with all current reg...

Theranos is closing its blood test facilities and laying off hundreds of employees

Technology : The Next Web Blog

In 2014, medical testing startup Theranos was valued at $9 billion after having developed a revolutionary blood test that only required a single drop per sample. After its results were found to be inaccurate, the company faced sanct...

Beyond Movie Material, Is Theranos Worth Anything?

Technology : Forbes: Tech

FORBES recently announced that the net worth ofElizabeth Holmes, founder and CEO of Theranos, a 13-year-old blood testing company, has fallen from $4.5 billion to $0. FORBESestimated Theranos was worth about $800 million and conclud...

Comments


Copyright © 2016 Regator, LLC